PM
SBBP

Prosight Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Prosight Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,258,224
Closed -$2.63M – 55
2019
Q4 		$2.63M Sell
1,258,224
-1,256,848
-50% -$2.41M 1.15% 24
2019
Q3 		$6.01M Sell
2,515,072
-31,925
-1% -$85.7K 3.33% 13
2019
Q2 		$7.97M Buy
2,546,997
+1,613,121
+173% +$5.92M 4.02% 11
2019
Q1 		$4.65M Sell
933,876
-4,024
-0.4% -$19.8K 2.03% 18
2018
Q4 		$4.2M Buy
937,900
+514,054
+121% +$2.51M 2.17% 20
2018
Q3 		$2.06M Buy
+423,846
New +$2.17M 1.15% 26

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Prosight Management's SBBP Position: Q1 2020 in Review

Prosight Management sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2020, closing a stake of 1,258,224 shares — an estimated $2.63M sold.

Prosight Management first reported a position in SBBP in Q3 2018 and held it in 6 quarters. The position peaked at $7.97M in Q2 2019. 60 funds tracked by Wall St. Rank hold SBBP as of Q1 2020.

  • Prosight Management reported no remaining Strongbridge Biopharma plc. position as of Q1 2020 after selling out during the quarter.
  • Prosight Management sold 1,258,224 Strongbridge Biopharma plc. shares in Q1 2020, an estimated $2.63M.
  • Prosight Management first reported a position in Strongbridge Biopharma plc. in Q3 2018 and held it in 6 quarters.
  • Prosight Management's Strongbridge Biopharma plc. position peaked at $7.97M in Q2 2019.
  • 60 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2020.

Based on Prosight Management's 13F filing for Q1 2020, filed 15 May 2020.